MINISTRY OF HEALTH HAS PUBLISHED THE COMMUNIQUE ON ARTICLES THAT ARE TREATED WITH BIOCIDAL PRODUCTS

Content addition date : 15-05-2018

Turkish Ministry of Health (MoH) has published the Communique on Treated Articles (Communique on articles which are treated with Biocidal Products) in the Official Gazette with No: 30420 on the date 13.05.2018. The communique has come into force on the date of publication.

In this respect, Treated Articles can be placed on the market only if the biocidal products which are used in the treatment of the articles, or intentionally incorporated into the treated articles, are registered or notified under the scope of the Turkish Biocidal Regulation

The application dosages of the biocidal products which are used in the treatment of the articles should in alignment with the suggested and verified (efficient) dosages of the registrant/ applicant of the biocidal product. 

The Biocidal claims shall be mentioned on the treated article labels only after the claims are verified.

Manufacturer and/or importer of the treated article, must prepare a technical dossier in accordance with the provisions of the communique. The technical dossier and the other documents needs to be kept available in case of CA audits or when demanded by the CA. 

Additionally, the CA commits that they will publish a Guidance about the enforcement of the Communique and make it available on their official website soon.

CRAD provides the below listed services for your company to comply with the Communique on Treated Articles:
•    Acting as OR for notification/registration of the Biocidal Products to be used for treating articles. 
•    Regulatory Compliance Support and Consultancy,
•    Label compliance
•    SDS compliance
•    Compilation of Technical Dossier
•    Analysis Process Management/Follow up
•    Communication with the Biocidal Product and/or Active Substance Supplier